Yonsei nomogram to predict lymph node invasion in Asian men with prostate c - Evidencio
Yonsei nomogram to predict lymph node invasion in Asian men with prostate cancer during robotic era
Current guidelines recommend performing pelvic lymph node dissection based on the estimated risk of lymph node invasion and several nomograms have been created to better predict this risk. However, the accuracy of these predictive models may be influenced by several factors. The characteristics of the study population are crucial in the performance of nomograms and ethnic differences in the behaviour of prostate cancer have been well documented.
Autores de la investigación: Kwang Hyun Kim, Sey Kiat Lim, Ha Yan Kim, Woong Kyu Han, Young Deuk Choi, Byung Ha Chung, Sung Joon Hong, Koon Ho Rha
Versión: 1.10
  • Público
  • Oncología
  • {{ modelType }}
  • Detalles
  • Validar algoritme
  • Guardar entrada
  • Entrada de carga
Mostrar
Unidades

{{ section.title }}

{{ section.description }}

Calcular el resultado

Establezca más parámetros para realizar el cálculo

The calculated risk for lymph node invasion is:

{{ resultSubheader }}
{{ $t('download_result_availability') }}
{{ chart.title }}
Intervalo de resultados {{ additionalResult.min }} a {{ additionalResult.max }}

Información condicional

No general consensus has been reached on how to decide the optimal nomogram cut-off value to recommend pelvic lymph node dissection. Existing guidelines and nomograms suggest a cut-off value which allows ≈50% of patients to be spared pelvic lymph node dissection while minimising missing patients with lymph node invasion. 
With a cutoff value of 4%, pelvic lymph node dissection could be omitted in 326 patients (60.2%), missing only two patients (4.4%) with lymph node invasion. The sensitivity, specificity, positive predictive value and negative predictive value were 95.6%, 65.3%, 20.0% and 99.4%, respectively

{{ file.classification }}
PRO
Nota
Las notas sólo son visibles en la descarga de resultados y no serán guardadas por Evidencio

Este algoritme se proporciona con fines educativos, formativos e informativos. No debe utilizarse para apoyar la toma de decisiones médicas ni para prestar servicios médicos o de diagnóstico. Lea nuestro disclaimer.

Algoritmer subyacentes Parte de
Comentarios
Comentario
Escriba un comentario
Los comentarios son visibles para cualquiera

Comentarios sobre el algoritme

Aún no hay comentarios 1 comentario {{ model.comments.length }} Comentarios
En {{ comment.created_at }} {{ comment.user.username }} un autor ya no registrado escribió:
{{ comment.content }}
logo

Inicia sesión para activar las funciones de impresión de Evidencio

Para poder utilizar las funciones de impresión de Evidencio, debe estar conectado.
Si no tiene una cuenta de la Comunidad Evidencio puede crear su cuenta personal gratuita en:

https://www.evidencio.com/registration

Resultados impresos - Ejemplos {{ new Date().toLocaleString() }}


Beneficios de la Cuenta Comunitaria Evidencio


With an Evidencio Community account you can:

  • Create and publish your own prediction algorithms.
  • Share your prediction algorithms with your colleagues, research group, organization or the world.
  • Review and provide feedback on algorithms that have been shared with you.
  • Validate your algorithms and validate algorithms from other users.
  • Find algorithms based on Title, Keyword, Author, Institute, or MeSH classification.
  • Use and save prediction algorithms and their data.
  • Use patient specific protocols and guidelines based on sequential algorithms and decision trees.
  • Stay up-to-date with new algorithms in your field as they are published.
  • Create your own lists of favorite algorithms and topics.

A personal Evidencio account is free, with no strings attached!
Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction algorithms.


Descargo de responsabilidad: Los cálculos por sí solos nunca deben dictar la atención al paciente, y no sustituyen al juicio profesional.
Evidencio v3.38 © 2015 - 2025 Evidencio. Todos los derechos reservados